Home > Back to Publisher > Report Information

Global HIV Market: An Analysis

Koncept Analytics
February 1, 2009
25 Pages - SKU: KOAN2104194

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

HIV is a lentivirus and attacks immune system which leads to death. The continuous research has developed treatment for HIV which has made a separate market for HIV drugs. The HIV drug market is increasing due to increasing awareness and diagnosis rates. There are around five million people in low and middle income countries who do not have access to AIDS drugs. HIV is very common in Southern African region. Botswana and Zimbabwe are the most affected countries; HIV is the most underlying reason for more than one third of all deaths among children under age of five.

In Japan, unwanted teen pregnancy is rising which may drive HIV drugs market in near future. Also the innovation of new drugs is driving HIV market; research continues to remain a significant unmet medical need for effective treatment.

The report outlines major countries affected from HIV virus and death rates. It also gives an overview of HIV virus and therapies in demand. The report presents overview of global market, HIV in US, UK, Asia and Sub-Saharan Africa. It highlights major markets for HIV drugs with overall market value and major drugs revenue.

The report discusses the opportunities prevailing in the HIV drugs market and issues affecting the growth. It also talks about competition prevalent in the market. It profiles major players with an overview of their business, key financials and business strategies.

1. Industry Overview: 1.1 Introduction; 1.2 Treatment for HIV
2. Market Size: 2.1 Global HIV Market; 2.4 United Kingdom
3. HIV Drugs Market: 3.1 Market Value; 3.2 Drug Revenue Comparison
4. Market Trends: 4.1 Opportunities in HIV Drug Market
5. Major Market Players: 5.1 Competition
6. Market Forecast: 6.1 People Receiving Therapy Projections
List of Tables: Nucleoside Reverse Transcriptase Inhibitors (NRTIs); Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs); Protease Inhibitors (PIs); HIV/AIDS Worldwide Cases/Deaths (2007); US AIDS Diagnosis (2006); Transmission Category of HIV (2006); Sub-Saharan Africa Cases/Deaths (2007); HIV/AIDS Diagnosed Cases in UK by Gender (2000-08); HIV/AIDS Diagnosed Cases in UK by Region (2000-08); China AIDS Statistics (2007); Major Players Growth Comparison (2007); Gilead Revenue by Geography (2005-07); Idenix Revenue by Products (2006-07); Bristol-Myers Squibb Revenue by Business Segments (2005-07); First-line Therapy Projections (2008-13E); People Receiving Antiretroviral Therapy (2006-08E); List of Charts; Worldwide HIV/AIDS Cases (2006); Children Living with HIV Globally (2007); Top Ten Reported AIDS Cases in US by Region (2006); HIV Prevalence in Pakistan by Region (2007); Global HIV Drugs Market (2004-07); Global HIV Drugs Revenue Comparison (2006); Global HIV Drugs Revenue Comparison (2007); Ranking of America’s Largest Pharma Corporations (2007); Top Biotechnology Companies (2006)

More Global AIDS, HIV & STDs Reports

2012 Global Syphilis Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country by Venture Planning Group
The report presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

2012 Global HIV/AIDS Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country by Venture Planning Group
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2012 by GlobalData
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2012 provides data on the ...

Herpes Simplex Infections Global Clinical Trials Review, H1, 2012 by GlobalData
Herpes Simplex Infections Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Herpes Simplex Infections Global Clinical Trials Review, H1, 2012 provides data on the ...

Global Infectious Disease Treatment Market 2011-2014 by Infiniti Research Limited
TechNavio’s analysts forecast the Global Infectious Disease Treatment market to grow at a CAGR of 8.1 percent over the period 2011–2014. One of the key ...

See all reports like this >>

Global HIV Market: An Analysis

Share this report

Other tasks

Research Assistance

Related Markets

AIDS, HIV & STDs Reports

Free Alert Me service